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Background: Proteomic analysis was performed in post-nuclear supernatant (PNS) and Percoll-purified membranes
(PM) prepared from fore brain cortex of rats exposed to increasing doses of morphine (10–50 mg/kg) for 10 days.
Results: In PNS, the 10 up (↑)- or down (↓)-regulated proteins exhibiting the largest morphine-induced change were
selected, excised manually from the gel and identified by MALDI-TOF MS/MS: 1-(gi|148747414, Guanine deaminase),
↑2.5×; 2-(gi|17105370, Vacuolar-type proton ATP subunit B, brain isoform), ↑2.6×; 3-(gi|1352384, Protein disulfide-isomerase
A3), ↑3.4×; 4-(gi|40254595, Dihydropyrimidinase-related protein 2), ↑3.6×; 5-(gi|149054470, N-ethylmaleimide sensitive
fusion protein, isoform CRAa), ↑2.0×; 6-(gi|42476181, Malate dehydrogenase, mitochondrial precursor), ↑1.4×; 7-(gi|
62653546, Glyceraldehyde-3-phosphate dehydrogenase), ↑1.6×; 8-(gi|202837, Aldolase A), ↑1.3×; 9-(gi|31542401,
Creatine kinase B-type), ↓0.86×; 10-(gi|40538860, Aconitate hydratase, mitochondrial precursor), ↑1.3×. The
identified proteins were of cytoplasmic (1, 4, 5, 7, 9), cell membrane (2), endoplasmic reticulum (3) and
mitochondrial (6, 8, 10) origin and 9 of them were significantly increased, 1.3-3.6×. The 4 out of 9 up-regulated proteins
(4, 6, 7, 10) were described as functionally related to oxidative stress; the 2 proteins participate in genesis of apoptotic
cell death.
In PM, the 18 up (↑)- or down (↓)-regulated proteins were identified by LC-MS/MS and were of plasma membrane [Brain
acid soluble protein, ↓2.1×; trimeric Gβ subunit, ↓2.0x], myelin membrane [MBP, ↓2.5×], cytoplasmic [Internexin, ↑5.2×;
DPYL2, ↑4.9×; Ubiquitin hydrolase, ↓2.0×; 60S ribosomal protein, ↑2.7×; KCRB, ↓2.6×; Sirtuin-2, ↑2.5×; Peroxiredoxin-2,
↑2.2×; Septin-11, ↑2.2×; TERA, ↑2.1×; SYUA, ↑2.0×; Coronin-1A, ↓5.4×] and mitochondrial [Glutamate dehydrogenase 1,
↑2.7×; SCOT1, ↑2.2×; Prohibitin, ↑2.2×; Aspartate aminotransferase, ↓2.2×] origin. Surprisingly, the immunoblot analysis
of the same PM resolved by 2D-ELFO indicated that the “active”, morphine-induced pool of Gβ subunits represented
just a minor fraction of the total signal of Gβ which was decreased 1.2x only. The dominant signal of Gβ
was unchanged.
Conclusion: Brain cortex of rats exposed to increasing doses of morphine is far from being adapted. Significant
up-regulation of proteins functionally related to oxidative stress and apoptosis suggests a major change of energy
metabolism resulting in the state of severe brain cell “discomfort” or even death.
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Morphine is one of the most effective painkillers. Re-
peated exposure of experimental animals to morphine
results in tolerance to this drug, development of physical
dependence and a chronic relapsing disorder – drug ad-
diction [1-5]. Physical dependence contributes to a drug
seeking behavior and the continuous drug use with
the aim to prevent the onset of unpleasant withdra-
wal symptoms. To name just few, morphine-induced
changes of brain function were associated with alterna-
tions of synaptic connectivity [6], neurotransmission [7],
specific signaling cascades [8], energy metabolism [9]
and stability of protein molecules [10].
Hyper-sensitization or super-activation of adenyl cyclase
(AC) activity by prolonged exposure of cultured cells or
mammalian organism to morphine has been demon-
strated in previous studies of mechanism of action of this
drug [1-5] and considered as biochemical basis for devel-
opment of opiate tolerance and dependence.
Our previous work on isolated Percoll® membranes (PM)
prepared from brain cortex of rats exposed to morphine for
10 days (10–50 mg/kg) indicated a desensitization of G-
protein response to μ-OR (DAMGO) and δ-OR (DADLE)
stimulation [11] and specific increase of ACI (8x) and ACII
(2.5×) isoforms [12]. The κ-OR (U-23554)-stimulated [35S]
GTPγS binding and expression level of ACIII-IX in PM
was unchanged. Behavioral tests of morphine-treated ani-
mals indicated that these animals were fully drug-
dependent (opiate abstinence syndrome) and developed
tolerance to subsequent drug addition (analgesic tolerance -
hot-plate and hind paw withdrawal tests). The increase of
ACI and ACII was interpreted as a specific compensatory
response to prolonged stimulation of brain cortex OR by
morphine.
Proteomic analysis represents a useful approach for an in-
vestigation of the overall changes of protein composition in-
duced by the short-term or prolonged use of drugs. The aim
of our present work was to identify proteins which are sig-
nificantly altered in brain cortex of rats exposed to the in-
creasing, high doses of morphine for prolonged period of
time (10 days). For this aim, the post-nuclear supernatant
fraction (PNS) was analyzed because it contains proteins of
mitochondrial, endoplasmic reticulum, plasma membrane as
well as cytoplasmic origin. In the second part of our work,
we extended these studies by analysis of protein composition
in membrane fraction isolated in Percoll gradient (PM).
Results
Two-dimensional electrophoresis and protein
identification in post-nuclear supernatant prepared
from brain cortex of control and morphine-treated rats;
analysis by MALDI-TOF MS/MS
Samples of PNS were extracted in ice-cold aceton/TCA/
96% ethanol, resolved by 2D-ELFO in linear IPG strips(pH 3–11) and 10% w/v acrylamide/0.26% w/v bis-
acrylamide gels as described in methods and stained
with silver or colloidal Coomassie blue. The stained 2D
gels were scanned with an imaging densitometer and
quantified by PDQuest software.
About 440 protein spots were recognized by silver
staining and PDQuest analysis of gels in both types of
PNS (Figure 1, left panels); when stained in colloidal
Coomassie blue, about 200 spots were recognized. In
CBB-stained gels, proteins 1–10 with different mobility
in (+M10) and (−M10) samples were selected for identifi-
cation by MALDI-TOF MS/MS as described in methods
(Figure 1, right panels). The detailed list of the altered
and identified proteins is presented in Additional file 1:
Table S1 and Table 1. These tables also include descrip-
tion of the subcellular localization and function of these
proteins.
The identified proteins were of cytoplasmic (1-Guanine
deaminase, ↑2.5×; 4-Dihydropyrimidinase-related protein
2,↑3.6×; 5-N-ethylmaleimide sensitive fusion protein,
isoform CRAa, ↑2.0×; 7-Glyceraldehyde-3-phosphate de-
hydrogenase, ↑1.6×; 9-Creatine kinase B-type, ↓0.86), cell
membrane (2-Vacuolar-type proton ATPase, subunit B,
brain isoform), ↑2.6x), endoplasmic reticulum (3-Protein
disulfide-isomerase A3, ↑3.4×) and mitochondrial (6-Malate
dehydrogenase, mitochondrial precursor, ↑1.4x; 8-Aldolase
A, ↑1.3×; 10-Aconitate hydratase, mitochondrial precursor,
↑1.3x) origin. The 9 of them were significantly increased,
1.3-3.6x. Correlation with functional properties of these
proteins indicated up-regulation of proteins related
to guanine degradation (1), vacuolar acidification (2),
apoptotic cell death (3), oxidative stress (4, 6, 7, 10),
membrane traffic (5) and glycolysis (8). All together, the
spectrum of the altered proteins suggests a major alter-
nation of brain cortex tissue when exposed to increasing
doses of morphine. The most significant change from
functional point of view was up-regulation of proteins
related to oxidative stress (see discussion for further
details).
Two-dimensional electrophoresis and protein
identification in Percoll-purified membranes isolated
from brain cortex of control and morphine-treated rats;
analysis by LC-MS/MS
PM samples were resolved by 2D-electrophoresis in the
same way as described for PNS. The resolution in
10% w/v acrylamide/0.26% w/v bis-acrylamide gels was
used in the case of silver staining; 12.0% w/v acrylamide/
0.32% w/v bis-acrylamide gels were used for staining in
CBB. About 300 protein spots were recognized by silver
(Figure 2, left panels); when stained in CBB, the total
number of detected protein spots was 490 (Figure 2,
right panels). Proteins 1–18 with an altered mobility in






















Figure 1 Two-dimensional gel electrophoresis maps of PNS prepared from control (A) and morphine-treated (B) rats. Protein samples
(600 μg for both Silver and CBB staining) were separated in the first dimension on pH 3–11 IPG strips. For resolution in the second dimension,
SDS-PAGE was performed in 10% w/v acrylamide/0.26% w/v bis-acrylamide gel. The stained 2D gels were scanned in an imaging densitometer
and quantified by PDQuest software. The process of quantification of the difference between morphine-treated (+M10) and control (−M10)
samples included spot detection, gel matching and spot quantification. Master gel was constructed for each group (+M10) or (−M10) as a
synthetic image that contains the spot data from all the gels in the MatchSet. At least four replicates were performed for each group/sample.
All matched and unmatched spots were then checked in a manual manner. Protein levels altered at least two-fold were taken into consideration.
About 200 protein spots totally were recognized by CBB silver staining by PDQuest analysis. Proteins 1–10 with an altered mobility in (+M10)
versus (−M10) samples were excised from in CBB-stained gels and identified by MALDI TOF/TOF analyzer as described in methods. Left panels,
Silver staining; Right panels, CBB staining.
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list of altered and identified proteins is presented in
Additional file 2: Table S2 and Table 2. These tables also
include a brief description of subcellular localization
and function of these proteins as well as quantitative
estimate of their relative change induced by morphine-
treatment.
The identified up (↑)- or down (↓)-regulated proteins
were of plasma membrane [1-BASP1, Brain acid solubleprotein 1, ↓2.1×; 2-GBB1, Guanine nucleotide-binding
protein subunit beta-1, ↓2.0×], myelin membrane [17-
MBP, Myelin basic protein S, ↓2.5×], cytoplasmic [3-
KCRB, Creatine kinase B-type (EC 2.7.3.2), ↓2.6x; 4-AINX,
Alpha-internexin, ↑5.2×; 5-DPYL2, Dihydropyrimidinase-
related protein 2, ↑4.9×; 6-SIRT2, NAD-dependent deace-
tylase sirtuin-2, ↑2.5×; 7-SYUA, Alpha-synuclein, ↑2.0×;
8-PRDX2, Peroxiredoxin-2, ↑2.2×; 9-TERA, Transitio-
nal endoplasmic reticulum ATPase, ↑2.1×; 13-UCHL1,








Protein characterization - PNS
Guanine deaminase Up-regulated Cytoplasm Metabolism Purine metabolism, guanine degradation [13]
V-type proton ATP
subunit B, brain isoform









Up-regulation of this protein causes apoptotic cell death [15],







Neuronal development and polarity [8], cone collapse and cell











Metabolism L-malate dehydrogenase activity, protein self-association; up-
regulation of the mitochondrial malate dehydrogenase is caused




Up-regulated Cytoplasm Metabolism Glyceraldehyde-3-phosphate dehydrogenase and nitrosylase
activities; surprising role in apoptosis [20]; is known as a major
target protein in oxidative stress [21]
Aldolase A Up-regulated Mitochondrion Metabolism Role in glycolysis and gluconeogenesis, scaffolding protein;
potential role in regulating the free intracellular concentration of
InsP3, and subsequently intracellular calcium dynamics[22,23]; the
expression of aldolase A may be regulated by chronic lithium
administration [24]
Creatine kinase B-type Down-
regulated




Up-regulated Mitochondrion Metabolism Isomerization of citrate to isocitrate via cis-aconitate;an iron-sulfur
protein, the particular susceptibility to oxidative damage may be
related to the iron-sulfur cluster [4Fe-4S]in its active site [26]
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COR1A, Coronin-1A, ↓5.4×, 16-SEP11, Septin-11, ↑2.2×;
18-RL12, 60S ribosomal protein L12, ↑2.7×] and mito-
chondrial [10-DHE3, Glutamate dehydrogenase 1, ↑2.7×;
11-SCOT1, Succinyl-CoA:3-ketoacid-coenzyme A transfer-
ase 1, ↑2.2×; 12-AATM, Aspartate aminotransferase, ↓2.2×;
14-PHB, Prohibitin, ↑2.2×] origin.
Thus, the only member of GPCR-initiated signaling cas-
cades identified by LC-MS/MS was trimeric Gβ subunit,
which was decreased 2× in PM samples prepared from
morphine-adapted rats. The morphine-induced decrease
of Gβ subunit in PM was subsequently verified by immu-
noblot analysis of the same 2D-gels as those used for
preparation of samples for LC-MS/MS (Figure 3). The
spot 2 (compare with Figure 2) represented just a small
fraction of the total signal of Gβ subunits which was dis-
tributed over wider range of pI. The total signal of Gβ was
decreased 1.2x only. We have divided the signal of Gβ in
CBB-stained gels into 8 small spots according to immuno-
blot signal (Figure 3) in order to verify it. Proteomic ana-
lysis was performed by LC-MS/MS and positive signal
was detected in spots 3, 4, 5, 7 and 8 (Table 3).
Therefore, the decrease of Gβ determined by prote-
omic analysis (2×) has to be regarded as an alternationof relatively small fraction of numerous forms of Gβ
resolved by 2D-ELFO. Morphine-induced decrease of
Gβ is selectively oriented to specific, minority compo-
nent of this protein; the dominant pool of Gβ subunits
is unchanged.
Discussion
Opium extracts from the plant Papaver somniferum have
been used for therapeutic and recreational purposes for
thousands of years. Opioid alkaloids and related pharma-
ceuticals are the most effective analgesics for the treat-
ment of acute and chronic pain. They also represent one
of the largest components of the illicit drug market
worldwide, generating revenue of approximately $70 bil-
lion in 2009, much of which supports crime, wars and
terrorism. Intravenous use of opioid drugs is a leading
cause of death by overdose in Europe and North America,
and a major contributing factor to the worldwide AIDS
epidemic [50,51].
Morphine and codeine are the main active opioid alka-
loids in opium. In humans, they act on the central ner-
vous system to produce a wide range of effects including
analgesia, euphoria, sedation, respiratory depression and
cough suppression. Chronic opiate administration results
Figure 2 Two-dimensional gel electrophoresis maps of protein extracts prepared from PM of control (A) and morphine-treated (B) rats.
Protein samples (400 μg for Silver staining; 2 mg for CBB staining) were separated in the first dimension on pH 3–11 IPG strips. For resolution
in the second dimension, SDS-PAGE was performed in 10% w/v acrylamide/0.26% w/v bis-acrylamide gel (silver staining) or in 12.5% w/v
acrylamide/0.0625% w/v bis-acrylamide gel (CBB staining). The stained 2D gels were scanned in an imaging densitometer and quantified by
PDQuest software. The process of quantification of the difference between morphine-treated (+M10) and control (−M10) samples included spot
detection, gel matching and spot quantification. Master gel was constructed for each group (+M10) or (−M10) as a synthetic image that contains
the spot data from all the gels in the MatchSet. At least four replicates were performed for each group/sample. All matched and unmatched spots
were then checked in a manual manner. Protein levels altered at least two-fold were taken into consideration. About 500 protein spots totally
were recognized by CBB staining by PDQuest analysis. Proteins 1–18 with an altered mobility in (+M10) versus (−M10) samples were excised from
in CBB-stained gels and identified by LC-MS/MS as described in methods. Left panels, Silver staining. Right panels, Coomassie staining.
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regulation of MOR and DOR function during this
process is not clearly understood.
To localize changes of MOR-stimulated G-protein
activity in various brain regions after chronic morphine
treatment, Sim et al. [52] examined [35S]GTPγS binding
to brain sections by in vitro autoradiography. Rats were
treated for 12 d with increasing doses (10–320 mg . kg-1
. d-1) of morphine. Control rats were injected with eithersaline or a single acute injection of morphine (20 mg/kg).
[35S]GTPγS binding was measured in the presence or ab-
sence of MOR-selective agonist DAMGO. In rats injected
with a single acute dose of morphine, no significant changes
were detected in basal or DAMGO-stimulated [35S]GTPγS
binding in any brain region. In chronic morphine-treated
rats, however, DAMGO-stimulated [35S]GTPγS binding in
cerebral cortex was significantly decreased when compared
with control rats. Similar data were obtained in analysis of






Functional category Protein characterization - PM









Associated with the membranes of growth cones that form
the tips of elongating axons, DNA-dependent, localizes in
the membrane raft domain with a cholesterol-dependent
manner; changes in the localization during the develop-






Cell membrane Signaling Gβ1 is required for neural tube closure, neural progenitor
cell proliferation and neonatal development [28]; stimulated
ACII, ACIV, ACVII, inhibited ACI, ACV/VI, ACVIII [29,30]
Creatine kinase B-type Down-
regulated
Cytoplasm Metabolism Energy-related (skeletal muscle, heart, brain and
spermatozoa), brain development [25], aging [31]; one of
major determinants in the control of oxidative stress [17]
Alpha-internexin Up-regulated Cytoplasm Neuronal
development and
regulation
Copurifies with intermediate filaments from rat spinal cord
and optic nerve, developmental protein involved in






Neuronal development and polarity [8], cone collapse and




Up-regulated Cytoplasm Cellular development
and regulation
Colocalizes with microtubules; NAD-dependent deacetylase,
involved in the control of mitotic exit in the cell cycle;
up-regulation may protect the brain against incurred
oxidative damage [33]
Alpha-synuclein Up-regulated Cytoplasm Neuronal
development and
regulation
Specifically expressed in neuronal cell bodies and synapses,
negative regulation of neuron apoptosis, aging; role in the
pathogenesis of Parkinson’s disease [34]
Peroxiredoxin-2 Up-regulated Cytoplasm Neuronal
development and
regulation
Involved in redox regulation of the cell, negative regulation
of neuron apoptosis; the relative abundance appears to
protect cellular components by removing the low levels of
hydroperoxides and peroxinitrites produced as a result of







Involved in the formation of the transitional endoplasmatic
reticulum, necessary for the fragmentation of Golgi stacks
during mitosis and for their reassembly after mitosis [36];







Metabolism Glutamate catabolic process, long-term memory, in rat brain
the glutamate dehydrogenase reaction operates in the dir-
ection of ammonia production [38]
Succinyl-CoA:3-ketoacid-




Metabolism A mitochondrial ketone body-activating enzyme [39]; brain








Metabolism Amino acid metabolism, metabolite exchange between
mitochondria and cytosol, fatty acid transport; its activity is
related with the maintenance of amino acid homeostasis














Involved both in the processing of ubiquitin precursors and
of ubiquitinated proteins; the ubiquitination/proteasome





Antiproliferative activity, role in regulating mitochondrial
respiration activity and aging, response to drug [42-44];
down-regulation of prohibitin renders neurons more
vulnerable to injury and reactive oxygen species






Invagination of plasma membrane, forming protrusions
of plasma membrane involved in cell locomotion;
coronin-1A activity is spatially and temporally regulated by
phosphoinositides [46]
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Table 2 Functional significance of proteins identified in PM fraction as altered by chronic morphine (Continued)
Septin-11 Up-regulated Cytoplasm Cellular development
and regulation
Filament-forming cytoskeletal GTPase, cell division; it is
involved in dendritic maturation [47]





Myelination, negative regulation of axonogenesis; morphine






Cytoplasm Regulatory Binds directly to 26S ribosomal RNA; it accesses the
importin 11 pathway as a major route into the nucleus [49]
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administration [53,54]. Accordingly, our analysis of PM iso-
lated from cerebral cortex of rats exposed to morphine for
10 days (10–50 mg/kg) indicated significant desensitization
of G-protein response to MOR and DOR stimulation [11]
and up-regulation of ACI and II [12].
Proteome changes after prolonged morphine exposure
have been so far investigated in “frozen tissue powders” of
the rat cerebral cortex, hippocampus, striatum [55,56] and
nucleus accumbens [7] or in the “whole-cell lysates” of stri-
atal neuronal cell cultures [57]. Therefore, the aim of our
work was to perform proteomic analysis in more defined
preparations: post-nuclear supernatant (PNS) and mem-
branes isolated in Percoll® gradient (PM). The morphine-
induced changes in protein composition (proteom) of PNS
and PM were determined by 2D-electrophoresis resolution
and PDQuest analysis; the altered proteins were identified




















1 2 3 4 5 6 7 8
Figure 3 Gβ subunit protein; immunoblot analysis of 2D-gels. A Two-d
control and morphine-adapted rats. PM protein (400 μg) was resolved by 2
the first dimension. The white small circle shows the small fraction of the t
analyzed by LC-MS/MS. The second dimension was performed by SDS-PAG
Gβ was identified by immunoblotting with specific antibody as described i
subunits which were subsequently analyzed by LC-MS/MS. B The average o
analyzed by Student’s t-test using GraphPadPrizm4 and found not significanProteomic analysis of PNS indicated a marked increase
of proteins of mitochondrial and cytoplasmic origin
(Additional file 1: Table S1 and Table 1). The 9 out of 10
proteins exhibiting the largest morphine-induced change
in Coomassie stained gels were increased by morphine:
1-Guanine deaminase, ↑2.5×; 2-Vacuolar-type proton ATP
subunit B, brain isoform ↑2.6×; 3-Protein disulfide-
isomerase A3, ↑3.4×; 4-Dihydropyrimidinase-related pro-
tein 2, ↑3.6x; 5-N-ethylmaleimide sensitive fusion protein,
isoform CRAa, ↑2.0×; 6-Malate dehydrogenase, mitochon-
drial precursor, ↑1.4×; 7-Glyceraldehyde-3-phosphate de-
hydrogenase, ↑1.6×; 8-Aldolase A, ↑1.3×; 10-Aconitate
hydratase, mitochondrial precursor, ↑1.3×. The 4 out of 9
up-regulated proteins (4, 6, 7, 10) were described as
functionally related to manifestation of oxidative stress
conditions [17,19,21,26]. Marked increase of Protein
disulfide-isomerase A3 (3) causing apoptotic cell death







1 2 3 4 5 6 7 8
imensional resolution of Gβ protein content in PM isolated from
D electrophoresis using the pI range 3–11 for isoelectric focusing in
he total signal of Gβ which was taken into consideration when
E in 10% w/v acrylamide/0.26% bis-acrylamide gels (Hoefer SE 600).
n Material and methods. The numbers 1–8 represent spots of Gβ
f 3 immunoblots ± SEM. Difference between (−M10) and (+M10) was
t, NS (p > 0.05).
Table 3 Proteomic analysis of Gβ subunits isolated from brain cortex of control and morphine-treated rats
Spot Accession Protein name Mascot Matched Peptides SCa MWb pIc
number score peptides [%] (kDa)
3 GBB1_RAT Guanine nucleotide-binding protein 184.3 6 R.LFDLR.A 16.8 37.4 5.6
subunit beta-1 R.LLVSASQDGK.L
K.LWDVR.E
K.IYAMHWGTDSR.L + Oxidation (M)
K.ACADATLSQITNNIDPVGR.I
K.VHAIPLR.S
4 GBB1_RAT Guanine nucleotide-binding protein 471 12 K.ACADATLSQITNNIDPVGR.I 32.9 37.4 5.6
subunit beta-1 R.LFVSGACDASAK.L










4 GBB2_RAT Guanine nucleotide-binding protein 413.9 10 R.TFVSGACDASIK.L 14.4 37.3 5.6
subunit beta-2 K.ACGDSTLTQITAGLDPVGR.I







R.LLLAGYDDFNCNIWDAMK.G + Oxidation (W)
5 GBB1_RAT Guanine nucleotide-binding protein 199.1 5 R.AGVLAGHDNR.V 14.1 37.4 5.6
subunit beta-1 R.LFVSGACDASAK.L
R.LFDLR.A
K.IYAMHWGTDSR.L + Oxidation (M)
R.LLVSASQDGK.L
5 GBB2_RAT Guanine nucleotide-binding protein 188.7 5 R.AGVLAGHDNR.V 3.5 37.3 5.6
subunit beta-2 R.TFVSGACDASIK.L
R.LFDLR.A
K.IYAMHWGTDSR.L + Oxidation (M)
R.LLVSASQDGK.L
7 GBB (1–4)_RAT Guanine nucleotide-binding protein 22.4 1 K.LLVSASQDGK.L 2.9 37.2 5.4
subunit beta-3
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hydrogenase (7), already mentioned as major target pro-
tein in oxidative stress [21]. The 4 out of 9 up-regulated
proteins (4, 6, 7, 10) were thus functionally related to
manifestation of the state of oxidative stress/oxidative
damage in brain of morphine-exposed rats and 2 proteins
were related to apoptotic cell death.
More detailed analysis of Percoll-purified membranes
indicated a complex reorganization of PM protein com-
position. The list of proteins presented in Additional file
2: Table S2 and Table 2 indicates that morphine-induced
alternation included increase as well as decrease of wide
range of proteins functionally and structurally related to
plasma, myelin, endoplasmic reticulum and mitochon-
drial membranes. Numerous soluble enzymes present
in soluble, cytosol fraction or in mitochondrial matrix
were also altered by chronic morphine. Surprisingly,
with the exception of trimeric Gβ subunit, not just one
of these proteins was functionally related to GPCR-
or ionic-channel-activated signaling cascades. Similarly,
proteomic analysis of protein alternations induced in the
long-term TRH-treatment of HEK cells expressing TRH-R
and G11α protein indicated the change of 42 proteins, but
not even one of these proteins represented plasma mem-
brane protein functionally related to GPCR-initiated signal-
ing cascades [58].
Our results indicate that the energy metabolism of rat
brain cortex exposed to increasing doses of morphine
(10–50 mg/kg, 10 days) is shifted far from the normal,
physiological state. Using other words, brain cortex of rats
exposed to morphine according to our protocol is far from
being adapted. It may be suggested that the both neuronal
and glial cells undergo a drastic reorganization as conse-
quence of cell discomfort and, subsequently, oxidative
stress. Simultaneous activation of all types of opioid recep-
tors (μ-, δ- and κ-OR) by high doses of morphine results
in high energy demand of neurons [59,60]. Consequently,
glycogen in astrocytes as the single largest energy reserve
in the brain is mobilized with the aim to match these
increased energy requirements [61]. After depletion of
glycogen in astrocytes, the state of oxidative stress appears
[62] as the full supply of oxygen to brain mitochondria is
not accompanied by transfer of the sufficient number of
“reducing equivalents” into the mitochondrial matrix.
Conclusions
Proteomic analysis of rat brain cortex of rats exposed
to morphine for 10 days (10–50 mg/kg) indicated a sig-
nificant morphine-induced change of membrane pro-
tein composition. Changes in post-nuclear supernatant
were exclusively based on increase (1.3-3.6×) of proteins
of mitochondrial and cytoplasmic origin. In isolated
plasma membranes (PM), morphine-induced alterna-
tion included increase as well as decrease of wide rangeof proteins functionally and structurally related to plasma,
myelin, endoplasmic reticulum and mitochondrial mem-
branes. Numerous soluble enzymes present in soluble,
cytosol fraction or in mitochondrial matrix were also
altered by chronic morphine. The only member of GPCR-
initiated signaling cascades identified by LC-MS/MS in
Percoll-purified membranes was trimeric Gβ subunit
(2-GBB) which was decreased 2x in samples prepared
from morphine-adapted rats. This “active” component
of Gβ subunits, however, represented a minor pool of
total complement of Gβ molecules in PM, which was
unchanged.Material and methods
Chemicals
Acrylamide, bis-acrylamide and Coomassie Blue G-250
were from SERVA (Heidelberg, Germany), nitrocellu-
lose membrane was from Whatman (Germany). Immo-
biline Dry-Strips, Pharmalyte buffer, and secondary
anti-rabbit antibody labeled with horseradish peroxidase
were purchased from GE Healthcare (Piscataway, NJ).
Complete protease inhibitor cocktail was from Roche
Diagnostic, Mannheim, Germany (cat. no. 1697498). All
others chemicals were from Sigma-Aldrich and were of
highest purity available. Primary antibody oriented
against trimeric Gβ subunit protein (T-20, sc-378) was
from Santa Cruz.Animals
Male Wistar rats (220-250 g) were killed by decapita-
tion under ether narcosis, the frontal brain was rapidly
removed, washed intensively from the remaining blood
and cooled to 0ºC. The cerebral cortex was separated on
the pre-cooled plate, snap frozen in liquid nitrogen and
stored at −70°C until use. The experiments were
approved by Animal Care and Use Committee of the
Institute of Physiology, Academy of Sciences of the
Czech Republic to be in agreement with Animal Protec-
tion Law of the Czech Republic as well as European
Comunity Council directives 86/609/EEC.Morphine treatment of experimental animals
The animals were exposed to morphine by intra-muscular
application according to the following protocol: 10 mg/kg
(day 1 and 2), 15 mg/kg (day 3 and 4), 20 mg/kg (day 4
and 5), 30 mg/kg (day 6 and 7), 40 mg/kg (day 9) and,
finally 50 mg/kg (day 10). The morphine-adapted rats
were sacrificed 24 hours after the last dose of the drug
(group +M10). Control animals were injected with sterile
PBS and sacrificed in parallel with morphine-treated rats,
i.e. 24 hours (group −M10) after the last dose [12].
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preparation of post-nuclear supernatant (PNS) and
percoll-purified membranes (PM)
Rat brain cortex was minced with razor blade on pre-
cooled plate and diluted in STEM medium containing
250 mM sucrose, 20 mM Tris–HCl, 3 mM MgCl2, 1 mM
EDTA, pH 7.6, fresh 1 mM PMSF plus protease inhibitor
cocktail. It was then homogenized mildly in loosely-fitting
Teflon-glass homogenizer for 5 min (2 g w. w. per 10 ml)
and centrifuged for 5 min at 3500 rpm (1200 × g). Result-
ing post-nuclear supernatant (PNS) was filtered through
Nylon nets of decreasing size (330, 110 and 75 mesh,
Nitex) and applied on top of Percoll in Beckman Ti70
tubes (30 ml of 27.4% Percoll in STE medium). Centrifu-
gation for 60 min at 30000 rpm (65000 × g) resulted in
the separation of two clearly visible layers (Bourova et al.,
2009). The upper layer represented plasma membrane
fraction (PM); the lower layer contained mitochondria
(MITO). The upper layer was removed, diluted 1:3 in
STEM medium and centrifuged in Beckman Ti70 rotor
for 90 min at 50000 rpm (175000 × g). Membrane sedi-
ment was removed from the compact, gel-like sediment
of Percoll and re-homogenized by hand in a small volume
of 50 mM Tris–HCl, 3 mM MgCl2, 1 mM EDTA, pH 7.4
(TME medium).
SDS-PAGE and immunoblotting
The aliquots of membrane fractions were mixed 1:1 with
2x concentrated Laemmli buffer (SLB) and heated for
3 min at 95 °C. Standard (10% w/v acrylamide/0.26% w/v
bis-acrylamide) SDS electrophoresis was carried out as
described before [63-65]. Molecular mass determina-
tions were based on pre-stained molecular mass markers
(Sigma, SDS 7B). After SDS-PAGE, proteins were trans-
ferred to nitrocellulose and blocked for 1 h at room
temperature in 5% (w/v) low-fat milk in TBS-Tween buf-
fer [10 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.1% (v/v)
Tween 20]. Antibodies were added in TBS-Tween con-
taining 1% (w/v) low-fat milk and incubated for at least
2 h. The primary antibody was then removed and the blot
washed extensively (3x10 min) in TBS-Tween. Secondary
antibodies (donkey anti-rabbit IgG conjugated with horse-
radish peroxidase) were diluted in TBS-Tween containing
1% (w/v) low-fat milk, applied for 1 h and after three
10 min washes, the blots were developed by ECL tech-
nique using Super Signal West Dura (Pierce) as substrate.
The developed blots were scanned with an imaging densi-
tometer ScanJett 5370C (HP) and quantified by Aida
Image Analyzer v. 3.28 (Ray test).
Sample preparation for isoelectric focusing
Samples of PNS or PM containing 400–600 μg protein
or 2 mg protein, respectively, were precipitated with ice
cold aceton overnight at – 20°C. After centrifugation at16 000 × g for 20 min at 4˚C, the supernatant was re-
moved and the pellet was precipitated with ice-cold 6%
TCA for 1.5 h on ice. After centrifugation at 16 000 × g
for 10 min at 4˚C, the supernatant was discarded and
the pellet washed with 400 μl of ice-cold 96% ethanol
for 1 h at room temperature. The mixture was centri-
fuged at 16 000 × g for 10 min at 4˚C and the remaining
pellet was solubilizated with 250 μl IEF sample buffer
containing 7 M urea, 2 M thiourea, 4% CHAPS, 1%
DTT, 1% ampholines pH 3–10 and 0.01% bromphenol
blue for 3 h at room temperature. After a brief centrifu-
gation (16 000 × g, 1 min), the sample was transferred
into a groove of the Immobiline DryStrip Reswelling
Tray (GE Healthcare).
Two-dimensional electrophoresis (2D-ELFO)
Immobiline DryStrips (linear pH gradient 3–11 NL,
13 cm) were placed into the Immobiline DryStrip Reswel-
ling Tray containing protein samples and rehydrated
overnight.
Isoelectric focusing was performed using the Multi-
phor II system (GE Healthcare) at 15˚C in the following
manner: 150 V for 5 h, 500 V for 1 h, 3500 V for 12 h
and 500 V for 3 h. The focused strips were stored at –
20˚C or immediately used.
Strips were rinsed thoroughly with ultrapure water,
dried quickly on filter paper and equilibrated in 4 ml of
equilibration buffer (50 mM Tris–HCl pH 6.8, 6 M urea,
0.1 mM EDTA, 2% SDS, 30% glycerol and 0.01% bromo-
phenol blue) containing 1% DTT for 15 min in order to
reduce disulphide bridges and other oxidized groups.
Subsequently, the strips were alkylated in equilibra-
tion buffer containing 2.5% iodoacetamide for 15 min.
Molecular weight markers were loaded onto a piece of
filter paper and placed close to the alkaline side of the
strip. The strip and molecular marker were covered with
0.5% agarose. Gels were run vertically at a constant
current of 10 mA for 20 min and then at 80 mA for 2 h
till the bromophenol blue dye reached the end of the gel.
The apparatus was cooled to 15˚C using the Hoefer SE
600 unit (GE Healthcare).
Silver staining
Silver staining was performed by ProteoSilver™ Plus
Silver Stain Kit (Sigma-Aldrich) according to the manu-
facturer’s instructions [66-68]. Briefly, the gel was fixed
in 40% ethanol/10% acidic acid overnight and then
washed by 30% ethanol for 10 min and once by ultra-
pure water for 10 min. The gels were incubated for
10 min with 1% Sensitizer solution and washed twice
with 200 ml of ultrapure water for 10 min. The gels were
submerged in 1% Silver solution for 10 min, washed with
200 ml of ultrapure water for 1 min and developed with
100 ml of the Developer solution until the desired
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solution was added to the Developer solution and gels
were incubated for 5 min. All steps were carried out at
room temperature on an orbital shaker at 60 to 70 rpm.
The gels were stored in fresh, ultrapure water or dried
in 3% glycerol/25% methanol.
Colloidal coomassie staining
For MS analysis, the gels were stained by colloidal
Coomassie Blue G-250 [69]. The gel was fixed in 40%
methanol/5% orthophosphoric acid for 12 h and incu-
bated with colloidal Coomassie Blue (17% ammonium
sulphate, 34% methanol, 3% orthophosphoric acid and
0.1% Coomassie G-250) for 48 h. After staining, the
gels were kept in 1% acetic acid at 4˚C.
Image analysis
The stained 2D gels were scanned with an imaging densi-
tometer ScanJett 5370C (HP) and quantified by PDQuest
software (Bio-Rad, version 7.3.1). The process included
spot detection, gel matching and spot quantification.
Master gel was constructed as a synthetic image that
contains the spot data from all the gels in the MatchSet.
At least four replicates were performed for each sample.
All matched and unmatched spots were then checked in
a manual manner. Protein levels altered at least two-fold
were taken into consideration.
Preparation of samples for MALDI-TOF MS/MS; analysis of
post-nuclear fraction
Mass spectrometric analysis MALDI-TOF was per-
formed as described before [58]. The peak lists from the
MS spectra were generated by 4000 Series Explorer V
3.5.3 (Applied Biosystems/MDS Sciex) without smooth-
ing, peaks with local signal to noise ratio greater than 5
were picked and searched by local Mascot v. 2.1 (Matrix
Science) against nonredundant NCBI database of protein
sequences (11186807 sequences; 3815639892 residues).
Database search criteria were as follows-enzyme: trypsin,
taxonomy: Rattus norvegicus (66703 sequences), fixed
modification: carbamidomethylation, variable modifica-
tion: methionine oxidation, peptide mass tolerance:
120 ppm, one missed cleavage allowed. Only hits that
were scored as significant (P < 0.001) were included.
In-gel digestion and preparation of samples for LC-MS/
MS; analysis of percoll-purified membranes (PM)
Protein spots (from 2-DE: ca 1–2 mm in diameter) were
excised from the Coomassie-stained gels, and then proc-
essed as described by Shevchenko et al. [70]. Briefly, the
spots were first destained by incubation in 100 μl of
100 mM ammonium bicarbonate/acetonitrile (1:1, v/v)
with occasional shaking for 1 hour. After destaining, the
gel pieces were shrunk by dehydration in 500 μl ofacetonitrile, which was then removed and the gel pieces
were dried in a vacuum centrifuge. In further step, 100 μl
of 10 mM DTT in 100 mM ammonium bicarbonate was
added, and the proteins were reduced for 1 hour at 56°C.
After cooling to room temperature, the DTT solution was
replaced by roughly the same volume of 55 mM iodoace-
tamide in 100 mM ammonium bicarbonate, and the gels
were incubated at ambient temperature for 45 min in the
dark. Then the gel pieces were washed with 100 μl of
100 mM ammonium bicarbonate, and dehydrated by
addition 500 μl of acetonitrile. Subsequently, the liquid
phase was removed and the gel pieces were dried in a vac-
uum centrifuge.
Before the in-gel digestion, the gel pieces were cooled
in an ice-cold bath and swollen in a 100 μl of digestion
buffer containing trypsin (20 μg/ml) in 50 mM ammo-
nium bicarbonate, and the gel pieces were sonicated
(5 min), placed to air circulation thermostat, and incu-
bated overnight at 37°C. The volumes of solutions
needed for processing of the protein bands were four-
fold larger than the volumes for processing of the spots.
The supernatant of each spot was then transferred to
a new vial. The in-gel digestion was performed once
more the same way. The resulting tryptic peptides were
extracted with sonication (15 min) by 150 μl of extrac-
tion buffer (5% formic acid/acetonitrile, 1:2, v/v). Then
the solution was spun, the supernatants were transferred,
pooled and concentrated to dryness by lyophilization.
Dried extracts were stored at −80°C before analysis.
Analysis of tryptic digests with LC-MS/MS
Dried protein digests were dissolved in 20 μl of 1% formic
acid, centrifuged (10 000 × g, 5 min, 4°C) and the super-
natant transferred to inserts in vials. The nano-HPLC
apparatus used for protein digests analysis was a Proxeon
Easy-nLC (Proxeon, Odense, Denmark) coupled to a
maXis Q-TOF (quadrupole – time of flight) mass spec-
trometer with ultrahigh resolution (Bruker Daltonics,
Bremen, Germany) by nanoelectrosprayer. The nLC-MS/
MS instruments were controlled with the software pack-
ages HyStar 3.2 and micrOTOF-control 3.0. The data
were collected and manipulated with the software pack-
ages ProteinScape 2.0 and DataAnalysis 4.0 (Bruker
Daltonics).
The 3 μl of the peptide mixture were injected into a NS-
AC-11-C18 Biosphere C18 column (particle size: 5 μm,
pore size: 12 nm, length: 150 mm, inner diameter: 75 μm),
with a NS-MP-10 Biosphere C18 pre-column (particle
size: 5 μm, pore size: 12 nm, length: 20 mm, inner diam-
eter: 100 μm), both manufactured by NanoSeparations
(Nieuwkoop, Netherlands).
The separation of peptides was achieved via a linear gra-
dient between mobile phase A (water) and B (acetonitrile),
both containing 0.1% (v/v) formic acid. Separation was
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followed by gradient elution to 30% B at 70 min. The
next step was gradient elution to 50% B in 10 min, and
then a gradient to 100% B in 8 min was used. Finally, the
column was eluted with 100% B for 2 min. Equlibration
before the next run was achieved by washing the column
with 5% mobile phase B for 10 min. The flow rate was
0.25 μl min-1, and the column was held at ambient
temperature (25°C).
On-line nano-electrospray ionization (easy nano-ESI) in
positive mode was used. The ESI voltage was set at
+4.5 kV, scan time 1.3 Hz. Operating conditions: drying
gas (N2), 1 l min
-1; drying gas temperature, 160°C;
nebulizer pressure, 0.4 bar. Experiments were performed
by scanning from 100 to 2200m/z. The reference ion
used (internal mass lock) was a monocharged ion of
C24H19F36N3O6P3 (m/z 1221.9906). Mass spectra corre-
sponding to each signal from the total ion current chro-
matogram were averaged, enabling an accurate molecular
mass determination. All LC-MS/MS analyses were done
in duplicates.
Database searching
Data were processed using ProteinScape software. Pro-
teins were identified by correlating tandem mass spectra
to SwissProt databases, using the MASCOT searching
engine (http://www.matrixscience.com); Rattus norvegi-
cus as species. Trypsin was chosen as the enzyme par-
ameter. One missed cleavage was allowed, and an initial
peptide mass tolerance of ±10.0 ppm was used for MS
and ±0.05 Da for MS/MS analysis. Cysteines were as-
sumed to be carbamidomethylated, proline and lysine to
be hydroxylated, serine, threonine and tyrosine to be
phosphorylated, and methionine was allowed to be oxi-
dated. All these possible modifications were set to be
variable. Monoisotopic peptide charge was set to 1+, 2+
and 3+. The Peptide Decoy option was selected during
the data search process to remove false-positive results.
Only significant hits (MASCOT score ≥60, http://www.
matrixscience.com) were accepted.
Statistical analysis
In immunoblot assays, the significance of difference be-
tween data collected in control and morphine-treated
samples was analyzed by Student’s t-test by GraphPad-
Prizm4. Results represent the average ± S.E.M.
Protein determination
The method of Lowry was used for determination of
membrane protein. Bovine serum albumin (Sigma, Frac-
tion V) was used as standard. Data were calculated by
fitting the data with calibration curve as quadratic
equation.Additional files
Additional file 1: Table S1. Proteomic analysis of post-nuclear
supernatant prepared from brain cortex of control and morphine-treated
rats.
Additional file 2: Table S2. Proteomic analysis of PM fraction isolated
from brain cortex of control and morphine-treated rats.
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